Basal concentrations and responses to an oral glucose tolerance test of glucagon, GLP-1, GIP, CCK, and gastrin at baseline and after matched ~6% weight loss by a CD or a CRHP diet in individuals with T2D and overweight or obesity. This evidence concerns the gene GIP and type 2 diabetes mellitus.